Sees FY26 adjusted EBITDA margin 30%-31%.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXCM:
- Notable companies reporting after market close
- DXCM Earnings this Week: How Will it Perform?
- Largest borrow rate increases among liquid names
- Dexcom: Strong 2025 Outperformance, Durable CGM Growth Runway, and Upcoming Product Catalysts Support Buy Rating
- Dexcom: 2026 Reset Year Sets Stage for Renewed Growth and Upside Potential